Special Offer
| Chemical Structure | Cat. No. | Product Name | CAS No. |
|---|
 |
BCP00227 | 3,4-Diaminofurazan Hot Discount Bulk | 17220-38-1 |
3,4-Diaminofurazan is a building block used to prepare magnesium and zinc alkynylated salicylaldehyde-diamine Schiff base complexes.
|
|||
 |
BCP01928 | Adavosertib New Hot Discount | 955365-80-7 |
MK-1775 is a potent and selective Wee1 kinase inhibitor with an IC50 of 5.2 nM.
|
|||
 |
BCP02515 | WZ4002 New Discount | 1213269-23-8 |
WZ4002 is an EGFR T790M inhibitor(IC50<20nM).
|
|||
 |
BCP01857 | Ivacaftor New Discount Bulk | 873054-44-5 |
Ivacaftor is a CFTR activator (IC50 of 43 ± 38 nM).
|
|||
 |
BCP00216 | Dactolisib New Discount | 915019-65-7 |
BEZ235 (NVP-BEZ235) inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes. The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells.
|
|||
 |
BCP05748 | Vistusertib New Discount | 1009298-59-2 |
AZD2014 is a selective inhibitor of mTOR kinase. AZD2014 decreases p4EBP1 Thr37/46, inhibits the translation initiation complex and decreases overall protein synthesis. AZD2014 also inhibits the mTORC2 biomarkers pAKTSer473 and pNDRG1 Thr346. AZD2014 inhibits proliferation and induces cell death in breast cancer cell lines, including ER+ cell lines with acquired resistance to hormone therapy.
|
|||
 |
BCP07173 | Tezacaftor New Discount | 1152311-62-0 |
Tezacaftor, also known asVX-661, is CFTR modulator. VX-661 is potentially useful for treatment of cystic fibrosis disease. Cystic fibrosis (CF) is a genetic disease caused by defects in the CF transmembrane regulator (CFTR) gene, which encodes an epithelial chloride channel. The most common mutation, Δ508CFTR, produces a protein that is misfolded and does not reach the cell membrane. VX-661 can correct trafficking of Δ508CFTR and partially restore chloride channel activity.
|
|||
 |
BCP02329 | Dolutegravir New Discount | 1051375-16-6 |
Dolutegravir is an integrase inhibitor being developed for the treatment of human immunodeficiency virus (HIV)-1 infection by GlaxoSmithKline (GSK) on behalf of Shionogi-ViiV Healthcare LLC.
|
|||
 |
BCP02173 | Galunisertib Discount | 700874-72-2 |
LY2157299 is a novel selective small molecule transforming growth factor beta receptor (TGF-βR) kinase inhibitor with IC50 of 86 nM and 2 nM for TβR1 and 2 nM, respectively.
|
|||
 |
BCP02829 | Bedaquiline New Discount | 843663-66-1 |
Bedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti-tuberculosis drug.
|
|||
 |
BCP20294 | APR-246 New Hot Discount | 5291-32-7 |
APR-246 restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. PRIMA-1Met also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance.
|
|||
 |
BCP01776 | Trichostatin A New Discount | 58880-19-6 |
Trichostatin A is a selective and potent inhibitor of histone deacetylase (Ki = 3.4 nM).
|
|||
 |
BCP17698 | EAI045 New Discount | 1942114-09-1 |
EAI045 is an allosteric inhibitor that targets selected drug-resistant EGFR mutants.
|
|||
 |
BCP02523 | Roxadustat New Discount Bulk | 808118-40-3 |
Roxadustat (FG-4592) is an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor developed for the treatment of anemia.
|
|||
 |
BCP07911 | Etomoxir New Discount | 124083-20-1 |
Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
|
|||
 |
BCP20662 | LOXO-195 New Hot Discount | 2097002-61-2 |
LOXO-195 is a next-generation TRK kinase (TKI) inhibitor, with IC50s of 0.6±0.1 nM, <2.5 nM for TRKA and TRKC respectively.
|
|||
 |
BCP20339 | BMS986205 New Hot Discount | 1923833-60-6 |
BMS-986205 is a selective indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor.
|
|||
 |
BCP02532 | CAL-101 Discount | 870281-82-6 |
CAL-101 is a potent PI3K p110δ inhibitor with an IC50 of 65 nM.
|
|||
 |
BCP25378 | Physostigmine salicylate Discount | 57-64-7 |
Physostigmine salicylate is a reversible cholinesterase inhibitor, a parasympathomimetic alkaloid.
|
|||
 |
BCP17155 | GSK2330672 Hot Discount | 1345982-69-5 |
GSK2330672 is a highly potent, nonabsorbable ASBT(apical sodium-dependent bile acid transporter) inhibitor (hASBT IC50=42 ± 3 nM) which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.
|
|||
